A study published in the journal Decision Analysis unveils a powerful new tool to tackle the opioid crisis, offering a pathway to slash costs by nearly 30% while saving lives.
Researchers at Washington University and Stanford developed a cannabinoid compound that provides pain relief without ...
Street dealers across the U.S. are adding potent synthetic opioids to drug supplies in what federal officials say could be ...
Persica Pharma announces positive phase 1b Modic trial of PP353, a novel, non-opioid intradiscal injection to treat chronic low back pain: London, UK Thursday, March 6, 2025, 18:0 ...
SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...
The global opioid analgesics market is poised for substantial growth, projected to expand from USD 43.3 billion in 2023 to USD 72.0 billion by 2033, at a robust Compound Annual Growth Rate (CAGR) of 5 ...
The opioid-free group also had improved comfort and satisfaction scores. Perspective from Asif M. Ilyas, MD, MBA, FAAOS According to published results, a novel opioid-free pathway may provide ...
Q4 2024 Earnings Call Transcript March 6, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0 ...
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
The "Jack Reacher" author Lee Child told Business Insider he wants his book about the opioid crisis, "The Midnight Line," to be adapted for the show.
Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback